Treatment of relatively non-invasive breast cancer cells with TGF-β enhanced their invasiveness, as well as increasing the intensity of EMT 37, suggesting that TGF-β drives the EMT of cancer cells to increase their metastatic ability 38. The gene discussed is TGFB1; the disease is cancer.